YOUR SEARCH FOR Text 39 RESULTS
21 of Total
Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… In Europe , Opzelura (ruxolitinib) cream 15mg/g is approved for the treatment of …
22 of Total
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs |
… In Europe , Opzelura (ruxolitinib) cream 15mg/g is approved for the treatment of …
23 of Total
Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
… efficacy and safety of once-daily baricitinib 2-mg and 4-mg in adults with severe alopecia areata (AA), …
24 of Total
Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
… (HiSCR) at Week 12 and at both tested doses (45mg and 75mg). In addition, at Week 12, patients treated …
25 of Total
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates | Incyte
… In Europe , Opzelura (ruxolitinib) cream 15mg/g is approved for the treatment of …
26 of Total
Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… In Europe , Opzelura (ruxolitinib) cream 15mg/g is approved for the treatment of …
27 of Total
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
… areata and who were taking baricitinib 4mg saw at least 80% scalp hair coverage. There …
28 of Total
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs |
… general and administrative 190,704 120,788 58 % 513,358 349,934 47 % … to the same period in 2020, primarily due to $120 million of expense related to the purchase …
29 of Total
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance
… (benefit) for income taxes 80,615 120,020 529,116 570,444 Provision … assets, net 26,298 27,548 Inventory 120,959 56,938 Prepaid expenses and other …
30 of Total
Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
View all news Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs August 3, 2021 at 8:00 AM EDT PDF